Alignment Healthcare Inc [ALHC] stock is trading at $17.39, up 2.05%. An important factor to consider is whether the stock is rising or falling in short-term value. The ALHC shares have gain 4.26% over the last week, with a monthly amount glided 11.62%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alignment Healthcare Inc [NASDAQ: ALHC] stock has seen the most recent analyst activity on August 25, 2025, when KeyBanc Capital Markets upgraded its rating to a Overweight but kept the price target unchanged to $21 for it. Previously, Barclays upgraded its rating to Equal Weight on July 31, 2025, and kept the price target unchanged to $13. On December 03, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $17 on the stock. KeyBanc Capital Markets started tracking the stock assigning a Sector Weight rating. BofA Securities upgraded its rating to a Buy and raised its price target to $11 on May 30, 2024. Robert W. Baird started tracking with a Outperform rating for this stock on May 30, 2024, and assigned it a price target of $10. In a note dated May 08, 2024, Piper Sandler upgraded an Overweight rating on this stock and boosted its target price from $6 to $8.
Alignment Healthcare Inc [ALHC] stock has fluctuated between $9.15 and $21.06 over the past year. Currently, Wall Street analysts expect the stock to reach $21 within the next 12 months. Alignment Healthcare Inc [NASDAQ: ALHC] shares were valued at $17.39 at the most recent close of the market. An investor can expect a potential return of 20.76% based on the average ALHC price forecast.
Analyzing the ALHC fundamentals
Alignment Healthcare Inc [NASDAQ:ALHC] reported sales of 3.34B for the trailing twelve months, which represents a growth of 49.03%. Gross Profit Margin for this corporation currently stands at 0.12% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.01%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.44 and Total Capital is -0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.34.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.11 points at the first support level, and at 16.82 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.62, and for the 2nd resistance point, it is at 17.84.
Ratios To Look Out For
For context, Alignment Healthcare Inc’s Current Ratio is 1.66. Considering the valuation of this stock, the price to sales ratio is 1.03, the price to book ratio is 24.42.
Transactions by insiders
Recent insider trading involved General Atlantic (ALN HLTH), L, Director, that happened on Sep 17 ’25 when 6.25 million shares were sold. Director, GENERAL ATLANTIC, L.P. completed a deal on Sep 17 ’25 to sell 6.25 million shares. Meanwhile, Director KONOWIECKI JOSEPH S sold 16076.0 shares on Sep 16 ’25.
